Abstract:BACKGROUND:Sodium butyrate, a histone deacetylase inhibitor, can inhibit cell proliferation, and induce apoptosis and differentiation of various cancer cells. However, the role of sodium butyrate combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on lung cancer stem cells remains unclear. OBJECTIVE:To explore the effect of sodium butyrate combined with TRAIL on biological behaviors of lung cancer stem cells. METHODS:Magnetic bead separation was used to separate lung cancer stem cells (CD133+) from human lung adenocarcinoma A549 cells. After the lung cancer stem cells were treated with simple DMEM/F12, DMEM/F12 containing sodium butyrate (5 mmol/L), TRAIL (50 μg/L) or sodium butyrate combined with TRAIL, the cell proliferation within 96 hours of culture was determined by MTT assay; the apoptosis within 24 hours of culture was measured by flow cytometry; the cell migration within 48 hours of culture was detected by cell scratch test; the expression levels of pluripotent transcription factors (Oct4, Sox2 and Nanog) within 48 hours of culture were detected using western blot analysis. RESULTS AND CONCLUSION:The CD133+ lung cancer stem cells were successfully enriched from human lung adenocarcinoma A549 cells. MTT assay showed that sodium butyrate and TRAIL significantly inhibited the proliferation of lung cancer stem cells (P< 0.05), and the combination effect was even stronger (P < 0.05). Results from flow cytometry analysis and scratch test showed that sodium butyrate or TRAIL induced apoptosis and inhibited cell migration of lung cancer stem cells (P < 0.05), and the combination of sodium butyrate and TRAIL showed a stronger effect (P < 0.05). In addition, the expression levels of Oct4, Sox2 and Nanog were significantly down-regulated by sodium butyrate (P < 0.05), TRAIL or sodium butyrate combined with TRAIL, and the combination effect was stronger (P < 0.05). In conclusion, sodium butyrate and TRAIL have synergistic effects on lung cancer stem cells, indicating a new way for treatment of lung cancer.

Sodium Butyrate Enhances the Cytotoxic Effect of Etoposide in HDACi-Sensitive and HDACi-Resistant Transformed Cells

An Integrative Proteome-Based Pharmacologic Characterization and Therapeutic Strategy Exploration of SAHA in Solid Malignancies

Sodium Butyrate Inhibits Migration and Induces AMPK-mTOR Pathway-Dependent Autophagy and ROS-mediated Apoptosis Via the Mir-139-5p/bmi-1 Axis in Human Bladder Cancer Cells.

Sodium Butyrate Upregulates Expression of NKG2D Ligand MICA/B in HeLa and HepG2 Cell Lines and Increases Their Susceptibility to NK Lysis

Trastuzumab Enhances the Anti-Tumor Effects of the Histone Deacetylase Inhibitor Sodium Butyrate on a HER2-overexpressing Breast Cancer Cell Line

Suppression of HDAC2 by Sodium Butyrate Alleviates Apoptosis of Kidney Cells in Db/db Mice and HG-induced NRK-52E Cells

Synergistic Induction of Apoptosis in HeLa Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitor SAHA.

Sodium Butyrate Increases P-gp Expression in Lung Cancer by Upregulation of STAT3 and Mrna Stabilization of ABCB1

Abstract B018: Epigenetic targeting improves glioblastoma cell sensitivity to chemotherapy

Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells

Suberoyl Bis-Hydroxamic Acid Enhances Cytotoxicity Induced by Proteasome Inhibitors in Breast Cancer Cells.

Synergistic Induction of Apoptosis by HMG-CoA Reductase Inhibitor and Histone Deacetylases Inhibitor in HeLa Cells.

Effect of sodium butyrate combined with TRAIL on biological behaviors of lung cancer stem cells

Proteomics analysis of histone deacetylase inhibitor-resistant solid tumors reveals resistant signatures and potential drug combinations

Dual Effects of Sodium Butyrate on Hepatocellular Carcinoma Cells

Butyric acid enhances in vivo expression of hTNF-alpha in transduced melanoma cell line

Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment

Enhanced Apoptosis-inducing Effect of Etoposide on Leukemic Cell Lines M-07e and TF-1 by the Proteasome Inhibitor Z-LLL-CHO

HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells.

Synergistic Effect of Simultaneous versus Sequential Combined Treatment of Histone Deacetylase Inhibitor Valproic Acid with Etoposide on Melanoma Cells

[Synergistic Effect of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid with Imatinib on K562 Cells].